Fol. Biol. 2009, 55, 126-131
https://doi.org/10.14712/fb2009055040126
Total-tau and Phospho-tau(181Thr) in Cerebrospinal Fluid of Neurologically Intact Population Increase with Age
References
1. , J., Lucas, J. J., Perez, M., Hernandez, F. (2004) Role of tau protein in both physiological and pathological processes. Physiol. Rev. 84, 361-384.
<https://doi.org/10.1152/physrev.00024.2003>
2. , H., Braak, E. (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain section. Brain Pathol. 1, 213-216.
<https://doi.org/10.1111/j.1750-3639.1991.tb00661.x>
3. , J., Maier, M., Arda, S., Claus, A., Süssmuth, S. D., Kassubek, J., Tumani, H. (2005) Tau protein in cerebrospinal fluid is increased in patients with early multiple sclerosis. Mult. Scler. 11, 261-265.
<https://doi.org/10.1191/1352458505ms1159oa>
4. , L., Bussière, T, Buée-Scherrer, V., Delacourte, A., Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130.
<https://doi.org/10.1016/S0165-0173(00)00019-9>
5. , P. R., Fournier, R., Mermillod, B., Krause, K-H., Bouras, C., Irminger, I. (2004) Cerebrospinal fluid tau and Aβ42 concentrations in healthy subjects: delineation of reference intervals and their limitations. Clin. Chem. Lab. Med. 42, 396-407.
<https://doi.org/10.1515/CCLM.2004.071>
6. , C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., Frackowiak, R. S. J. (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21-36.
<https://doi.org/10.1006/nimg.2001.0786>
7. , C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., Blennow, K. (2001) Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 297, 187-190.
<https://doi.org/10.1016/S0304-3940(00)01697-9>
8. , P. R., Delacourte, A., Bouras, C. (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. 84, 45-51.
<https://doi.org/10.1007/BF00427214>
9. , B., Binder, H., Dragon, M., Poljansky, S., Haen, E., Schmitz, E., Koch, H., Putzhammer, A., Klueneman, H., Wieland, W., Hajak, G. (2006) Cerebrospinal fluid tau and β-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Neurobiol. Aging 27, 1202-1211.
<https://doi.org/10.1016/j.neurobiolaging.2005.06.005>
10. , B., Driscoll, L., Schall, M. (1997) Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol. 386, 661-680.
<https://doi.org/10.1002/(SICI)1096-9861(19971006)386:4<661::AID-CNE11>3.0.CO;2-N>
11. , G. V. W., Stoothoff, W. H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117, 5721-5729.
<https://doi.org/10.1242/jcs.01558>
12. , F. (2006) MRI-based volumetry of head compartments: normative values of healthy adults. Neuroimage 30, 1-11.
<https://doi.org/10.1016/j.neuroimage.2005.09.063>
13. , T., Ferreira, S., Dupont-Wallois, L., Bussiere, T., Dupire, M. J., Delacourte, A., Michalski, J. C., CailletBoudin, M. L. (2003) Evidence of balance between phosphorylation and O-GlcNAc glycosylation of tau proteins: a role in nuclear localization. Biochim. Biophys. Acta 1619, 167-176.
<https://doi.org/10.1016/S0304-4165(02)00477-4>
14. , A., Saiz, A., Bas, J., Hernandez, J. J., Graus, F., Arbizu, T. (2004) Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis. Neurosci. Lett. 363, 14-17.
<https://doi.org/10.1016/j.neulet.2004.03.039>
15. , E. B., Harrington, C. R., Roth, M., Wischis, C. M. (1996) Alteration in tau protein metabolism during normal aging. Dementia 7, 95-103.
16. , P., Valentino, F., Piccoli, T., Piccoli, F., La Bella, V. (2009) Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. Eur. J. Neurol. 16, 257-261.
<https://doi.org/10.1111/j.1468-1331.2008.02405.x>
17. , W., Selim, M. (1990) Corticonigral degeneration with neuronal achromias and basal neurofibrillary tangles. Acta Neuropathol. 81, 89-94.
<https://doi.org/10.1007/BF00662643>
18. , M., Lautenschlager, N., Wagenpfeil, S., Diehl, J., Drzezga, A., Kurz, A. (2002) Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch. Neurol. 59, 1729-1734.
<https://doi.org/10.1001/archneur.59.11.1729>
19. , M., Wagenpfeil, S., Vanderstichele, H., Otto, M., Wiltfang, J., Kretzschmar, H., Vanmechelen, E., Förstl, H., Kurz, A. (2003) Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol. Psych. 8, 343-347.
<https://doi.org/10.1038/sj.mp.4001220>
20. , P., Pantel, J., Hunt, A., Volkmann, M., Buerger, K., Hampel, H., Schröder, J. (2003) Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer’s diasease. Neurosci. Lett. 339, 172-174.
<https://doi.org/10.1016/S0304-3940(02)01481-7>
21. , M., Matsubara, E., Murakami, T., Manabe, Y., Abe, K., Kanai, M., Ikeda, M., Tomidokoro, Y., Shizuka, M., Watanabe, M., Amari, M., Ishiguro, K., Kawarabayashi, T., Harigaya, Y., Okamoto, K., Nishimura, T., Nakamura, Y., Takeda, M., Urakami, K., Adachi, Y., Nakashima, K., Arai, H., Sasaki, H., Kanemaru, K., Yamanouchi, H., Yoshida, Y., Ichise, K., Tanaka, K., Hamamoto, M., Yamamoto, H., Matsubayashi, T., Yoshida, H., Toji, H., Nakamura, S., Hirai, S. (2002) Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiol. Aging 23, 363-370.
<https://doi.org/10.1016/S0197-4580(01)00309-8>
22. , M., Vanderstichele, H., Ågren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L-O., Marcusson, J., Nägga, K., Andreasen, N., Davidson, P., Vanmechelen, E., Blennow, K. (2001) Tau and Aβ42 in cerebrospinal fluid from healthy adults 2193 years of age: establishment of reference values. Clin. Chem. 47, 1776-1781.
<https://doi.org/10.1093/clinchem/47.10.1776>
23. , A., Stenset, V., Gundersen, A. S., Fladby, T. (2008) Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cer. Fluid Res. 5, 1-8.
24. , I., Vanmechelen, E., Andreasson, L. A., Palmertz, B., Davidsson, P., Hesse, C., Blennow, K. (1995) A population based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 4, 433-442.
<https://doi.org/10.1006/neur.1995.0052>
25. , G., Kostović, I., Winblad, B., Bogdanović, N. (1997) Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer’s disease. J. Comp. Neurol. 379, 482-494.
<https://doi.org/10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z>
26. , H., De Vreese, K., Blennow, K., Andreasen, N., Sindic, C., Ivanoiu, A., Hampel, H., Bürger, K., Parnetti, L., Lanari, A., Padovani, A., Diluca, M., Bläser, M., Ohrfelt Olsson, A., Pottel, H., Hulstaert, F., Vanmechelen, E. (2006) Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU(181P) assay for discrimination between Alzheimer’s disease and dementia with Lewy bodies. Clin. Chem. Lab. Med. 44, 1472-1480.
<https://doi.org/10.1515/CCLM.2006.258>
27. , E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van der Perre, B., Sjögren, M., Andreasen, N., Blennow, K. (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with syntethic phosphopeptide for standardization. Neurosci. Lett. 285, 49-52.
<https://doi.org/10.1016/S0304-3940(00)01036-3>
28. , M. D., Lockwood, A. H., Hwo, S-Y., Kirschner, M. W. (1975) A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA 72, 1858-1862.
<https://doi.org/10.1073/pnas.72.5.1858>
